STOCK TITAN

Maximus SEC Filings

MMS NYSE

Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Maximus, Inc. filings document the regulatory record of a public government-services contractor with common stock listed under MMS. Its 8-K reports cover quarterly and annual operating results, financial condition, earnings guidance, capital-return actions, stock repurchase authorizations and senior officer changes.

The company’s proxy materials describe board elections, auditor ratification, advisory executive-compensation votes, equity compensation disclosures and shareholder voting results. Together, the filings address Maximus’s governance structure, executive compensation, common-stock capital actions and formal disclosures related to its U.S. Federal Services, U.S. Services and Outside the U.S. operating segments.

Rhea-AI Summary

Altman Anne K. reported acquisition or exercise transactions in this Form 4 filing.

MAXIMUS, INC. director Anne K. Altman reported receiving an equity award of 3,062 shares of Common Stock at no cash cost, characterized as a grant or award. This represents restricted stock units that vest one year from the grant date and include 13.83 dividend-equivalent rights tied to earlier RSU awards.

After this grant, Altman directly holds a total of 35,141.897 shares. The transaction is compensation-related rather than an open-market purchase or sale, so it reflects routine director remuneration instead of a change in personal trading stance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Warren Michael J. reported acquisition or exercise transactions in this Form 4 filing.

MAXIMUS, INC. director Michael J. Warren reported an award of 2,246 shares of Common Stock in the form of restricted stock units. These RSUs vest one year from the grant date, effectively adding to his equity-based compensation. Following this award and prior dividend-related adjustments, he holds 17,839.316 shares directly, reflecting both granted units and shares accumulated through dividend equivalents and reinvestment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MAXIMUS, INC. director Gayathri Rajan received an equity award of 2,246 shares of common stock in the form of restricted stock units that vest one year from the March 10, 2026 grant date. Following this grant, Rajan directly holds a total of 16,704.698 common shares, including dividend-equivalent rights and shares acquired through dividend reinvestment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Maximus held its Annual Meeting of Shareholders on March 10, 2026, with 50,864,001 shares represented, equal to 93.2% of the common stock entitled to vote. Shareholders elected eight directors to one-year terms ending at the 2027 annual meeting.

They also ratified KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year, with 50,814,166 votes for and 13,714 against. In addition, shareholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 48,075,519 votes for and 1,136,606 against.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

MAXIMUS, INC. director Richard A. Montoni reported an indirect disposition of common stock through a bona fide gift. On February 27, 2026, a trust associated with him transferred 7,000 shares of common stock as a gift to a family member at no price. Following this transaction, the trust’s indirect holdings stood at 45,500 common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MAXIMUS, INC. director Richard A. Montoni reported an indirect disposition of 3,000 shares of common stock through a bona fide gift. The shares were held in trust and were gifted to a charitable donor advised fund at no stated price. Following this gift transfer, indirect holdings reported for this trust-related position total 52,500 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Trusts associated with MAXIMUS, INC. director John J. Haley reported bona fide gifts of 32,764 shares of common stock each on February 18, 2026, at a reported price of $0.00 per share. After these transactions, Haley reports 39,971.489 shares held directly and additional indirect holdings through another trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Maximus, Inc. CEO and President Bruce Caswell reported open-market purchases of company common stock. On February 10, 2026, he bought 152 shares at a weighted average price of $76.92, 1,332 shares at $78.22, and 1,691 shares at $78.77. Following these transactions, he directly beneficially owned 328,013.285 shares of Maximus common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Maximus, Inc. director John J. Haley reported non-cash transfers of company stock involving personal and trust holdings. On 02/10/2026, he executed two bona fide gift transfers of Maximus common stock totaling 32,764 shares each at a stated price of $0 per share, moving shares between direct ownership and the John J. Haley Revocable Trust.

Following these transactions, Haley directly held 39,971.489 shares of Maximus common stock and indirectly held 32,764 shares through the revocable trust and 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven. A footnote explains that 32,764 shares previously held by a separate annuity trust (Trust Six) were transferred back to Haley as an annuity payment in an exempt transaction under Rule 16a-13.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Maximus, Inc. Chief Financial Officer David Mutryn reported an open-market purchase of company stock. On February 9, 2026, he bought 1,000 shares of Maximus common stock at a price of $75.625 per share. After this transaction, he directly owned 40,036.754 shares of Maximus common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Maximus (MMS) SEC filings are available on StockTitan?

StockTitan tracks 71 SEC filings for Maximus (MMS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Maximus (MMS)?

The most recent SEC filing for Maximus (MMS) was filed on March 12, 2026.